Nephritis, Hereditary

"Nephritis, Hereditary" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A group of inherited conditions characterized initially by HEMATURIA and slowly progressing to RENAL INSUFFICIENCY. The most common form is the Alport syndrome (hereditary nephritis with HEARING LOSS) which is caused by mutations in genes for TYPE IV COLLAGEN and defective GLOMERULAR BASEMENT MEMBRANE.

Descriptor ID	D009394
MeSH Number(s)	C12.706.742 C12.777.419.570.620 C13.351.875.742 C13.351.968.419.570.620 C16.131.939.742 C17.300.200.517
Concept/Terms	Nephritis, Hereditary Nephritis, Hereditary Hereditary Nephritis Nephritis, Familial Familial Nephritis Hereditary Interstitial Pyelonephritis Pyelonephritis, Hereditary Interstitial Hemorrhagic Hereditary Nephritis Hemorrhagic Hereditary Nephritis Nephritis, Hemorrhagic Hereditary Hemorrhagic Familial Nephritis Nephritis, Hemorrhagic Familial Hereditary Hematuria Syndrome Congenital Hereditary Hematuria Hematuria, Congenital Hereditary Hematuric Hereditary Nephritis Nephritis, Hematuric Hereditary Hereditary Familial Congenital Hemorrhagic Nephritis Alport Syndrome, Autosomal Recessive Alport Syndrome, Autosomal Recessive Alport Syndrome, X-Linked Alport Syndrome, X-Linked Alport Syndrome, X Linked X-Linked Alport Syndrome Alport Syndrome Alport Syndrome Syndrome, Alport Hematuria-Nephropathy-Deafness Syndrome Hematuria Nephropathy Deafness Syndrome Syndrome, Hematuria-Nephropathy-Deafness Alport's Syndrome Alport Syndrome, Autosomal Dominant Alport Syndrome, Autosomal Dominant

Below are MeSH descriptors whose meaning is more general than "Nephritis, Hereditary".

Diseases [C]
Male Urogenital Diseases [C12]
Urogenital Abnormalities [C12.706]
Nephritis, Hereditary [C12.706.742]
Urologic Diseases [C12.777]
Kidney Diseases [C12.777.419]
Nephritis [C12.777.419.570]
Nephritis, Hereditary [C12.777.419.570.620]
Female Urogenital Diseases and Pregnancy Complications [C13]
Female Urogenital Diseases [C13.351]
Urogenital Abnormalities [C13.351.875]
Nephritis, Hereditary [C13.351.875.742]
Urologic Diseases [C13.351.968]
Kidney Diseases [C13.351.968.419]
Nephritis [C13.351.968.419.570]
Nephritis, Hereditary [C13.351.968.419.570.620]
Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
Congenital Abnormalities [C16.131]
Urogenital Abnormalities [C16.131.939]
Nephritis, Hereditary [C16.131.939.742]
Skin and Connective Tissue Diseases [C17]
Connective Tissue Diseases [C17.300]
Collagen Diseases [C17.300.200]
Nephritis, Hereditary [C17.300.200.517]

Below are MeSH descriptors whose meaning is more specific than "Nephritis, Hereditary".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Nephritis, Hereditary" by people in this website by year, and whether "Nephritis, Hereditary" was a major or minor topic of these publications.

Bar chart showing 35 publications over 17 distinct years, with a maximum of 4 publications in 1994 and 1999

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1992	1	0	1
1994	3	1	4
1995	3	0	3
1996	1	0	1
1997	1	1	2
1998	2	0	2
1999	3	1	4
2000	3	0	3
2002	0	1	1
2004	1	0	1
2005	2	1	3
2006	1	0	1
2007	2	0	2
2008	2	1	3
2009	1	0	1
2010	1	1	2
2022	1	0	1

Below are the most recent publications written about "Nephritis, Hereditary" by people in Profiles.

Irion CI, Williams M, Capcha JC, Eisenberg T, Lambert G, Takeuchi LM, Seo G, Yousefi K, Kanashiro-Takeuchi R, Webster KA, Young KC, Hare JM, Shehadeh LA. Col4a3-/- Mice on Balb/C Background Have Less Severe Cardiorespiratory Phenotype and SGLT2 Over-Expression Compared to 129x1/SvJ and C57Bl/6 Backgrounds. Int J Mol Sci. 2022 Jun 15; 23(12).

View in: PubMed
LeBleu V, Sund M, Sugimoto H, Birrane G, Kanasaki K, Finan E, Miller CA, Gattone VH, McLaughlin H, Shield CF, Kalluri R. Identification of the NC1 domain of {alpha}3 chain as critical for {alpha}3{alpha}4{alpha}5 type IV collagen network assembly. J Biol Chem. 2010 Dec 31; 285(53):41874-85.

View in: PubMed
Bekheirnia MR, Reed B, Gregory MC, McFann K, Shamshirsaz AA, Masoumi A, Schrier RW. Genotype-phenotype correlation in X-linked Alport syndrome. J Am Soc Nephrol. 2010 May; 21(5):876-83.

View in: PubMed
LeBleu V, Sugimoto H, Mundel TM, Gerami-Naini B, Finan E, Miller CA, Gattone VH, Lu L, Shield CF, Folkman J, Kalluri R. Stem cell therapies benefit Alport syndrome. J Am Soc Nephrol. 2009 Nov; 20(11):2359-70.

View in: PubMed
Bhatt A, Broxson E, Witte D, Omoloja A. Thrombocytopenia and proteinuria. Nonmuscle myosin heavy-chain-9-related disease ( MYH9 RD) or Epstein syndrome (ES). Pediatr Nephrol. 2009 Mar; 24(3):485-8.

View in: PubMed
LeBleu VS, Kalluri R. Stem cell-based therapy for glomerular diseases: an evolving concept. J Am Soc Nephrol. 2008 Sep; 19(9):1621-3.

View in: PubMed
Lebleu VS, Sugimoto H, Miller CA, Gattone VH, Kalluri R. Lymphocytes are dispensable for glomerulonephritis but required for renal interstitial fibrosis in matrix defect-induced Alport renal disease. Lab Invest. 2008 Mar; 88(3):284-92.

View in: PubMed
Cosgrove D, Kalluri R, Miner JH, Segal Y, Borza DB. Choosing a mouse model to study the molecular pathobiology of Alport glomerulonephritis. Kidney Int. 2007 Apr; 71(7):615-8.

View in: PubMed
Hahm K, Lukashev ME, Luo Y, Yang WJ, Dolinski BM, Weinreb PH, Simon KJ, Chun Wang L, Leone DR, Lobb RR, McCrann DJ, Allaire NE, Horan GS, Fogo A, Kalluri R, Shield CF, Sheppard D, Gardner HA, Violette SM. Alphav beta6 integrin regulates renal fibrosis and inflammation in Alport mouse. Am J Pathol. 2007 Jan; 170(1):110-25.

View in: PubMed
Zeisberg M, Khurana M, Rao VH, Cosgrove D, Rougier JP, Werner MC, Shield CF, Werb Z, Kalluri R. Stage-specific action of matrix metalloproteinases influences progressive hereditary kidney disease. PLoS Med. 2006 Apr; 3(4):e100.

View in: PubMed

People

Explore

Similar Concepts

Top Journals